v3.26.3
REVENUES (Tables)
 9 Months Ended
Sep. 30, 2026
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
The Company’s Revenues by segment and by payer group were as follows:
Three Months Ended September 30, 2026Three Months Ended September 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients23 %— %— %23 %23 %— %— %23 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid8 %— %— %8 %8 %— %— %8 %
   Third party36 %— %— %36 %37 %— %— %37 %
Total Dx revenues77 %— %— %77 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs9 %9 %5 %23 %9 %9 %4 %22 %
Total Revenues
86 %9 %5 %100 %87 %9 %4 %100 %
Nine Months Ended September 30, 2026Nine Months Ended September 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients23 %— %— %23 %24 %— %— %24 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid8 %— %— %8 %8 %— %— %8 %
   Third party37 %— %— %37 %36 %— %— %36 %
Total Dx revenues78 %— %— %78 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs9 %9 %4 %22 %9 %9 %4 %22 %
Total Revenues87 %9 %4 %100 %87 %9 %4 %100 %
Contract with Customer, Asset and Liability [Table Text Block]
The following table provides information about accounts receivable and unbilled services from contracts with customers:
September 30, 2026December 31, 2025
Dx accounts receivable$1,624.7 $1,349.0 
BLS accounts receivable825.3 791.2 
Less: BLS allowance for credit losses(37.1)(36.4)
Accounts receivable, net$2,412.9 $2,103.8 
Gross unbilled services$148.7 $164.0 
Less: BLS allowance for credit losses(2.9)(7.1)
Unbilled services, net$145.8 $156.9 
Financing Receivable, Allowance for Credit Loss [Table Text Block] The rollforward for the allowance for credit losses was as follows:
Accounts Receivable, netUnbilled Services, netTotal
Balance at December 31, 2025$36.4 $7.1 $43.5 
Credit loss expense8.6 — 8.6 
Write-offs(7.6)(4.2)(11.8)
Foreign currency impact
(0.3)— (0.3)
Balance at September 30, 2026$37.1 $2.9 $40.0